Journal Article

DZNE-2020-04352

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders.

Hagen, K. (First author)DZNE* ; Ehlis, A.-C. ; Haeussinger, F. B. ; Beeretz, S. ; Kromer, G. V. ; Heinzel, S. ; Maetzler, W.DZNE* ; Eschweiler, G. W. ; Berg, D.DZNE* ; Fallgatter, A. J. ; Metzger, F. G. ; Consortium, T. S.

2015
Springer Wien [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00702-014-1351-7

Abstract: Vagus somatosensory evoked potentials (VSEP) have been shown to have higher latencies with aging, which are even more increased in patients with Alzheimer's disease and subjects with mild cognitive impairment compared to age-matched healthy controls. In this study, the association of VSEP with subjective memory impairment (SMI), a potential risk or prodromal marker for Alzheimer's disease, was examined. The association of VSEP latencies and SMI was studied in a healthy risk cohort, including 358 elderly subjects, who are in a longitudinal study of risk factors for neurodegenerative disorders. The results show increased VSEP latencies for peak P2 at Fz-F4 in subjects who report SMI and are worried about it as compared to subjects who report memory impairment, but are not concerned and subjects without complaints. The results support a potential role of VSEP for the detection of very early neurodegenerative processes which may precede Alzheimer's disease.

Keyword(s): Alzheimer Disease: diagnosis (MeSH) ; Cognitive Dysfunction: diagnosis (MeSH) ; Evoked Potentials, Somatosensory: drug effects (MeSH) ; Evoked Potentials, Somatosensory: physiology (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Memory Disorders: drug therapy (MeSH) ; Memory Disorders: physiopathology (MeSH) ; Middle Aged (MeSH) ; Neurodegenerative Diseases: diagnosis (MeSH) ; Neurodegenerative Diseases: drug therapy (MeSH) ; Neurodegenerative Diseases: physiopathology (MeSH) ; Perception (MeSH) ; Prospective Studies (MeSH) ; Risk (MeSH) ; Vagus Nerve: drug effects (MeSH) ; Vagus Nerve: physiopathology (MeSH)

---

Contributing Institute(s):

1. AG N.N. (AG N.N. 3)
2. Functional Neurogeriatrics (AG Maetzler)
3. Parkinson's Disease Genetics (AG Berg ; AG Berg)

Research Program(s):

1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)
2. 345 - Population Studies and Genetics (POF3-345) (POF3-345)

Appears in the scientific report 2015

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection

---